Wuhan University, Zhongnan Hospital, Department of Infectious Diseases, Hubei, Wuhan, China.
Rev Inst Med Trop Sao Paulo. 2022 Feb 14;64:e11. doi: 10.1590/S1678-9946202264011. eCollection 2022.
The effect of antiretroviral therapy (ART) on CD4+/CD25hi/CD127low T lymphocyte changes in people living with HIV/AIDS (PLWHA) is still a matter of debate. From October 2015 to December 2019, peripheral blood from 70 cases of PLWHA were collected for the detection of CD4+/CD25hi/CD127low T lymphocytes by flow cytometry. Statistical analysis was performed to detect changes of CD4+/CD25hi/CD127low T lymphocytes in patients with different duration of ART and different treatment effects. We found that the number of CD4+/CD25hi/CD127low T lymphocytes in ART-naive PLWHA were lower than those in healthy volunteers (10.3±٦.٠ cells/uL vs 31.7±8.0 cells/uL, P < 0.05). CD4+/CD25hi/CD127low T lymphocyte counts increased to 17.8±٤.٠ cells/uL 6 months post-ART and 25.0±١١.٩ cells/uL 9 months post-ART, respectively (P < 0.05). There was no significant difference in CD4+/CD25hi/CD127low T lymphocyte counts between PLWHA who reached a complete immune reconstruction after ART and healthy volunteers. The growth of CD4+/CD25hi/CD127low T lymphocyte counts in patients who had baseline CD4 > 200 cells/uL was greater than those who had baseline CD4 ≤ 200 cells/uL (12.6±٤.٦ cells/uL vs 5.6±٥.٠ cells/uL, P = 0.027). CD4+/CD25hi/CD127low T lymphocyte counts were positively correlated with CD4+ T lymphocyte counts (r = 0.923, P < 0.001) and CD4+/CD8+ ratio (r = 0.741, P < 0.001), but were negatively correlated with HIV-VL (r = -0.648, P = 0.000). In conclusion, the results of the present study showed that changes in CD4+/CD25hi/CD127low T lymphocyte counts can be used to assess the effect of ART in PLWHA.
抗逆转录病毒疗法(ART)对人类免疫缺陷病毒/艾滋病(PLWHA)患者 CD4+/CD25hi/CD127low T 淋巴细胞变化的影响仍存在争议。从 2015 年 10 月至 2019 年 12 月,采集了 70 例 PLWHA 的外周血,通过流式细胞术检测 CD4+/CD25hi/CD127low T 淋巴细胞。对不同 ART 时间和不同治疗效果患者的 CD4+/CD25hi/CD127low T 淋巴细胞变化进行了统计学分析。结果发现,ART 初治 PLWHA 的 CD4+/CD25hi/CD127low T 淋巴细胞数量低于健康志愿者(10.3±6.0 细胞/μL vs 31.7±8.0 细胞/μL,P<0.05)。ART 后 6 个月,CD4+/CD25hi/CD127low T 淋巴细胞计数增加至 17.8±4.0 细胞/μL,ART 后 9 个月增加至 25.0±11.9 细胞/μL(P<0.05)。ART 后完全重建免疫的 PLWHA 与健康志愿者的 CD4+/CD25hi/CD127low T 淋巴细胞计数无差异。基线 CD4>200 细胞/μL 的患者 CD4+/CD25hi/CD127low T 淋巴细胞计数的增长大于基线 CD4≤200 细胞/μL 的患者(12.6±4.6 细胞/μL vs 5.6±5.0 细胞/μL,P=0.027)。CD4+/CD25hi/CD127low T 淋巴细胞计数与 CD4+T 淋巴细胞计数(r=0.923,P<0.001)和 CD4+/CD8+比值(r=0.741,P<0.001)呈正相关,与 HIV-VL(r=-0.648,P=0.000)呈负相关。综上所述,本研究结果表明,CD4+/CD25hi/CD127low T 淋巴细胞计数的变化可用于评估 PLWHA 的 ART 疗效。
Zhonghua Yi Xue Za Zhi. 2002-10-25
PLoS Pathog. 2018-2-15
AIDS Rev. 2014
Front Immunol. 2013-7-30
Blood. 2012-10-4
J Virol. 2012-7-18